Clinical Trials Browser

NCT01409161 2026-05-20

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Phase 2 Recruiting

151 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT07586813 2026-05-14

N01-A-PICIT-GI

Phase 2 Recruiting

220 enrolled

Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

Phase 2 Recruiting

220 enrolled

BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

NCT05345002 2026-02-20

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Phase 2 Recruiting

55 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT06358677 2026-02-13

FACE

Phase 2 Recruiting

25 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04241276 2026-01-07

STARPAC2

Phase 2 Active not recruiting

170 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04113863 2025-12-18

ATRA

Phase 2 Terminated

76 enrolled

Breast

Breast Neoplasm Female

NCT06731140 2025-11-17

Resilire

Phase 2 Recruiting

10 enrolled

Breast

HER2 Negative Breast Cancer

NCT06528769 2025-09-30

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Phase 2 Recruiting

16 enrolled

Sarcoma

Leiomyosarcoma, Sarcoma